Harvest Capital Management Inc purchased a new position in shares of Danaher Co. (NYSE:DHR) in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm purchased 2,690 shares of the conglomerate’s stock, valued at approximately $250,000.

A number of other institutional investors also recently added to or reduced their stakes in the business. GQG Partners LLC purchased a new stake in shares of Danaher in the second quarter valued at $101,000. Zions Bancorporation grew its position in shares of Danaher by 118.3% in the third quarter. Zions Bancorporation now owns 1,231 shares of the conglomerate’s stock valued at $106,000 after purchasing an additional 667 shares during the period. Patten Group Inc. grew its position in shares of Danaher by 262.3% in the third quarter. Patten Group Inc. now owns 4,830 shares of the conglomerate’s stock valued at $114,000 after purchasing an additional 3,497 shares during the period. Monetary Management Group Inc. boosted its holdings in Danaher by 10.7% in the second quarter. Monetary Management Group Inc. now owns 1,550 shares of the conglomerate’s stock valued at $131,000 after acquiring an additional 150 shares during the last quarter. Finally, Acrospire Investment Management LLC boosted its holdings in Danaher by 185.5% in the second quarter. Acrospire Investment Management LLC now owns 1,693 shares of the conglomerate’s stock valued at $143,000 after acquiring an additional 1,100 shares during the last quarter. 76.05% of the stock is owned by institutional investors.

Danaher Co. (DHR) opened at $98.24 on Thursday. The company has a market capitalization of $67,790.00, a PE ratio of 29.24, a price-to-earnings-growth ratio of 2.07 and a beta of 1.03. Danaher Co. has a one year low of $78.97 and a one year high of $98.88. The company has a debt-to-equity ratio of 0.42, a quick ratio of 1.00 and a current ratio of 1.43.

Danaher (NYSE:DHR) last issued its quarterly earnings data on Thursday, October 19th. The conglomerate reported $1.00 EPS for the quarter, topping the Zacks’ consensus estimate of $0.95 by $0.05. The company had revenue of $4.53 billion for the quarter, compared to analysts’ expectations of $4.47 billion. Danaher had a return on equity of 11.29% and a net margin of 13.36%. The firm’s quarterly revenue was up 9.6% on a year-over-year basis. During the same quarter in the previous year, the firm posted $0.87 earnings per share. sell-side analysts expect that Danaher Co. will post 3.99 EPS for the current year.

The business also recently disclosed a quarterly dividend, which will be paid on Friday, January 26th. Shareholders of record on Friday, December 29th will be paid a dividend of $0.14 per share. This represents a $0.56 dividend on an annualized basis and a dividend yield of 0.57%. The ex-dividend date is Thursday, December 28th. Danaher’s dividend payout ratio is presently 16.67%.

In other Danaher news, CAO Robert S. Lutz sold 11,189 shares of the business’s stock in a transaction dated Monday, October 23rd. The stock was sold at an average price of $91.66, for a total transaction of $1,025,583.74. Following the transaction, the chief accounting officer now owns 18,314 shares in the company, valued at $1,678,661.24. The sale was disclosed in a legal filing with the SEC, which is available at the SEC website. Also, SVP Daniel Raskas sold 37,870 shares of the business’s stock in a transaction dated Thursday, November 16th. The stock was sold at an average price of $93.33, for a total value of $3,534,407.10. The disclosure for this sale can be found here. In the last 90 days, insiders have sold 273,810 shares of company stock worth $25,218,813. 12.20% of the stock is currently owned by insiders.

DHR has been the topic of a number of research analyst reports. Morgan Stanley lifted their target price on Danaher from $95.00 to $98.00 and gave the company an “overweight” rating in a report on Friday, October 20th. Credit Suisse Group lifted their target price on Danaher from $93.00 to $96.00 and gave the company an “outperform” rating in a report on Friday, October 20th. Zacks Investment Research upgraded Danaher from a “hold” rating to a “buy” rating and set a $97.00 target price on the stock in a report on Thursday, October 5th. Goldman Sachs Group reiterated a “neutral” rating and issued a $83.00 target price on shares of Danaher in a report on Tuesday, September 26th. Finally, Citigroup lifted their target price on Danaher to $107.00 and gave the company a “buy” rating in a report on Friday, December 15th. One investment analyst has rated the stock with a sell rating, six have assigned a hold rating, ten have issued a buy rating and one has issued a strong buy rating to the company’s stock. The company currently has a consensus rating of “Buy” and a consensus price target of $94.91.

WARNING: This report was first reported by Watch List News and is owned by of Watch List News. If you are accessing this report on another website, it was stolen and republished in violation of United States & international trademark and copyright legislation. The legal version of this report can be viewed at https://www.watchlistnews.com/harvest-capital-management-inc-purchases-new-stake-in-danaher-co-dhr/1802902.html.

About Danaher

Danaher Corporation (Danaher) designs, manufactures and markets professional, medical, industrial and commercial products and services. The Company operates through four segments: Life Sciences, which offers a range of research tools that scientists use to study the basic building blocks of life, including genes, proteins, metabolites and cells, in order to understand the causes of disease, identify new therapies and test new drugs and vaccines; Diagnostics; which offers analytical instruments, reagents, consumables, software and services; Dental, which provides products that are used to diagnose, treat and prevent disease and ailments of the teeth, gums and supporting bone, and Environmental & Applied Solutions, which consists of various lines of business, including water quality and product identification.

Institutional Ownership by Quarter for Danaher (NYSE:DHR)

Receive News & Ratings for Danaher Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Danaher and related companies with Analyst Ratings Network's FREE daily email newsletter.